The effect of selective antihypertensive drugs on the vascular remodeling-associated hypertension: Insights from a profilin1 transgenic mouse model

Journal of Cardiovascular Pharmacology

Volumn 57, Issue 5, 2011, Pages 550-558

  Hassona, Mohamed D H ^a,b,c   Elnakish, Mohammad T ^a,b   Abouelnaga, Zeinb A ^a,b   Alhaj, Mazin ^a,b   Wani, Altaf A ^a,c,d   Hassanain, Hamdy ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d HELWAN UNIVERSITY   (Egypt)

Author keywords

antihypertensive drugs; profilin1 gene; transgenic mice; vascular remodeling

Indexed keywords

ACETYLCHOLINE; ALPHA1 INTEGRIN; AMLODIPINE; ATENOLOL; BETA1 INTEGRIN; COMPLEMENTARY DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOSIN LIGHT CHAIN; PHENYLEPHRINE; PHOSPHOMYOSIN LIGHT CHAIN 20; PROFILIN; PROFILIN I; PROTEIN ROCKII; RHO KINASE; SODIUM NITRITE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SELECTIVITY; HUMAN; HYPERTENSION; MALE; MESENTERIC ARTERY; MOUSE; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; TRANSGENIC MOUSE; VASOCONSTRICTION; VASODILATATION; WESTERN BLOTTING;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HYPERTENSION; MALE; MESENTERIC ARTERIES; MICE; MICE, TRANSGENIC; MYOSIN LIGHT CHAINS; NITRIC OXIDE SYNTHASE TYPE III; PROFILINS; RHO-ASSOCIATED KINASES; VASODILATION;

EID: 79957716492     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318212b1c2     Document Type: Article

References (46)

1. Denardo SJ, Messerli FH, Gaxiola E, et al. Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST]. Am J Cardiol. 2010;106:498-503
2. Bakker ENTP, van der Meulen ET, van den Berg BM, et al. Inward remodeling follows chronic vasoconstriction in isolated resistance arteries. J Vasc Res. 2002;39:12-20 (Pubitemid 34158355)
3. Lund-Johanson P. Haemodynamics in early essential hypertension: still an area of controversy. J Hypertens. 1983;1:209-213
4. Moustafa-Bayoumi M, Alhaj MA, El-Sayed O, et al. Vascular hypertrophy and hypertension caused by transgenic overexpression of profilin1. J Biol Chem. 2007;282:37632-37639
5. Mulvany MJ. Small artery remodeling and significance in the development of hypertension. News Phys Sci. 2002;17:105-109
6. Wolinsky H, Glagov S. A lamellar unit of aortic medial structure and function in mammals. Circ Res. 1967;20:99-111
7. Kiechl S, Willeit J. The natural course of atherosclerosis. Part I: incidence and progression. Arterioscler Thromb Vasc Biol. 1999;19:1484-1490 (Pubitemid 29263018)
8. Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension. 2000;36:312-318
9. Then KL, Rankin JA. Hypertension: a review for clinicians. Nurs Clin N Am. 2004;39:793-814 (Pubitemid 39550536)
10. Intengan HD, Thibault G, Li JS, et al. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation 1999;100:2267-2275
11. Sharifi AM, Li JS, Endemann D, et al. Comparison of effects of the angiotensin converting enzyme inhibitor enalapril and the calcium channel antagonist amlodipine on small artery structure and composition, and on endothelial dysfunction in SHR. J Hypertens. 1998;16: 457-466
12. Siragy HM, Carey RM. The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3#,5#-monophosphate and AT1 receptormediated prostaglandin E2 production in conscious rats. J Clin Invest. 1996;97:1978-1982
13. Stoll M, Steckelings UM, Paul M, et al. The angiotensin AT2 receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651-657
14. Virdis A, Ghiadoni L, Sudano I, et al. Effects of antihypertensive drugs on endothelial function in humans. J Hypertens. 1998;16(Suppl 8): S103-S110 (Pubitemid 29118827)
15. Deng LY, Schiffrin EL. Effect of antihypertensive treatment on response to endothelin of resistance arteries of hypertensive rats. J Cardiovasc Pharmacol. 1993;21:725-731 (Pubitemid 23121869)
16. Intengan HD, Schiffrin EL. Disparate effects of carvedilol versus metoprolol treatment of stroke-prone spontaneous hypertensive rats on endothelial function of resistance arteries. J Cardiovasc Pharmacol. 2000; 35:763-768 (Pubitemid 30253618)
17. Matrougui K, Tankó LB, Loufrani L, et al. Involvement of rho-kinase and the actin filament network in angiotensin ii-induced contraction and extracellular signal-regulated kinase activity in intact rat mesenteric resistance arteries. Arterioscler Thromb Vasc Biol. 2001; 21:1288-1293 (Pubitemid 34219834)
18. Gurlek A, Dagalp Z, Oral D, et al. Restenosis after transluminal coronary angioplasty: a risk factor analysis. J Cardiovasc Risk. 1995;2:51-55
19. Glagov S. Intimal hyperplasia, vascular modeling, and the restenosis problem. Circulation. 1994;89:2888-2891 (Pubitemid 24173712)
20. Hassona MD, Abouelnaga ZA, Elnakish MT, et al. Vascular hypertrophyassociated hypertension of profilin1 transgenic mouse model leads to functional remodeling of peripheral arteries. Am J Physiol Heart Circ Physiol. 2010;298:H2112-H2120
21. Louis H, Kakou A, Regnault V, et al. Role of a1b1-integrin in arterial stiffness and angiotensin-induced arterial wall hypertrophy in mice. Am J Physiol Heart Circ Physiol. 2007;293:H2597-H2604 (Pubitemid 47605909)
22. Gimbrone MA, Nagel T, Topper JN. Biomechanical activation: an emerging paradigm in endothelial adhesion biology. J Clin Invest. 1997; 99:1809-1813 (Pubitemid 27175926)
23. Zhang ZH, Vuori K, Wang HG, et al. Integrin activation by R-Ras. Cell. 1996;85:61-69 (Pubitemid 26116807)
24. Alvarez E, Northwood IC, Gonzalez FA, et al. Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation: characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. J Biol Chem. 1991;266:15277-15285 (Pubitemid 21907645)
25. Martin M, Vozenin MC, Gault N, et al. Coactivation of AP-1 activity and TGF-1 gene expression in the stress response of normal skin cells to ionizing radiation. Oncogene. 1997;15:981-989 (Pubitemid 27399559)
26. Ming XF, Viswambharan H, Barandier C, et al. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol. 2002;22:8467-8477 (Pubitemid 35397163)
27. Duguay D, DeBlois D. Differential regulation of Akt, caspases and MAP kinases underlies smooth muscle cell apoptosis during aortic remodelling in SHR treated with amlodipine. Br J Pharmacol. 2007;151:1315-1323 (Pubitemid 47255901)
28. Kimura K, Ito M, Amano M, et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science. 1996;273:245-248 (Pubitemid 26285892)
29. Van der Loo B, Koppensteiner R, Luscher TF. How do blood vessels age? Vasa. 2004;33:3-11
30. Schiffrin EL, Deng LY. Structure and function of resistance arteries of hypertensive patients treated with a b-blocker or a calcium channel antagonist. J Hypertens. 1996;14:1247-1255 (Pubitemid 26343505)
31. Schiffrin EL, Park JB, Intengan HD, et al. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin antagonist losartan. Circulation. 2000;101:1653-1659 (Pubitemid 30196624)
32. Schiffrin EL, Deng LY, Larochelle P. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin converting enzyme inhibitor. Comparison with effects of a beta blocker. Am J Hypertens. 1995;8:229-236
33. Schiffrin EL, Deng LY. Comparison of effects of angiotensin converting enzyme inhibition and beta blockade on function of small arteries from hypertensive patients. Hypertension. 1995;25:699-703
34. Hai-bin L, Xiao-feng W, Bing LI. Effects of perindopril, amlodipine and dobutamine on permeability of rat aortic endothelial cell monolayers. J Chin Clin. 2007;2:7-11
35. Schiffrin EL, Touyz RM. From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol. 2004;287:H435-H446 (Pubitemid 38960790)
36. Mukai Y, Shimokawa H, Matoba T, et al. Involvement of Rho-kinase in hypertensive vascular disease-a novel therapeutic target in hypertension. FASEB. 2001;15:1062-1064
37. Birukov KG, Bardy N, Lehoux S, et al. Intraluminal pressure is essential for the maintenance of smooth muscle caldesmon and filamin content in aortic organ culture. Arterioscler Thromb Vasc Biol. 1998;11:922-927 (Pubitemid 28272586)
38. Romeo GR, Moulton KS, Kazlauskas A. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor- null mouse. Circ Res. 2007;101:357-367 (Pubitemid 47267704)
39. Domínguez-Jiménez C, Yánez-Mó M, Carreira A, et al. Involvement of a3 integrin/tetraspanin complexes in the angiogenic response induced by angiotensin II1. FASEB J. 2001;15:1457-1459
40. Friedrich EB, Clever YP, Wassmann S, et al. Role of integrin-linked kinase in vascular smooth muscle cells: regulation by statins and angiotensin II. Bioch Biophys Res Commun. 2006;349:883-889 (Pubitemid 44399827)
41. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001;38:581-587
42. Zervoudaki A, Economou E, Stefanadis C, et al. Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment. J Hum Hypertens. 2003;17:119-124 (Pubitemid 36292367)
43. Hu Y, Cheng L, HochleitnerBW, et al. Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler Thromb Vasc Biol. 1997;17:2808-2816 (Pubitemid 28016025)
44. Hamaguchi A, Kim S, Izumi Y, et al. Contribution of extracellular signalregulated kinase to angiotensin II-induced transforming growth factor-b1 expression in vascular smooth muscle. Cell Hypertens. 1999;34:126-131 (Pubitemid 29325730)
45. Akagawa O, Fujisawa K, Ishizaki T, et al. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett. 1996;392:189-193 (Pubitemid 26276745)
46. Seasholtz TM, Zhang T, Morissette MR, et al. Increased expression and activity of RhoA are associated with increased DNA synthesis and reduced p27 (Kip1) expression in the vasculature of hypertensive rats. Circ Res. 2001;89:488-495 (Pubitemid 34132642)